India's Orchid Pharma gains as US FDA completes facility check

Orchid Pharma

20/02/2025 04:19

** Shares of Orchid Pharma  ORCD.NS  rise 3% to 860 rupees
    ** The pharma co said US FDA completed inspection at its
Alathur, Tamil Nadu API facility, which resulted in seven minor
observations, none of which pertain to the data integrity of the
facility
    ** Adds, facility also secures EU GMP certificate renewal
for Cephalosporin API manufacturing
    ** Stock down 11% so far this week
     

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))